Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of Auration CR vs Tegretol CR in Healthy Males
NCT02132897Phase 1Completed
- Start
- May 2014
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Auration CR in epilepsy, trigeminal neuralgia (TN) and bipolar disorder (BD). Started May 2014; status: completed.
02
Drugs
Auration CR
03
Conditions
epilepsytrigeminal neuralgia (TN)bipolar disorder (BD)
Beyond the preview
Go deeper on NCT02132897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02132897.